[libribook.com] Traumatic Scar Tissue Management 1st Edition
Figure 4.9Neurofascial envelopes.
Clinical ConsiderationThe space between the distinct neurofascial coverings comprises a delicate,areolar CT much like that seen in the sliding layers associated with muscleand fascia. This layer is presumed to provide a similar sliding function andpresent with similar consequences when impacted by injury and trauma.Peripheral nerves – wrapped in their neurofascial envelopes – travel throughoutthe body within fascial clefts or cleavage planes that function as ‘neutral motioncorridors’. These protective corridors help safeguard the nerve from compressionand over extension. As the nerve and its protective coverings are connected viainvesting fibers, whatever impacts the various layers of the neurofascial corridorhas great potential to impact the enveloped nerve.
- Page 309 and 310: Primary lower lymphatic structuresT
- Page 311 and 312: Left side lymphatic drainageThe lef
- Page 313 and 314: Lymphatic System FunctionsA brief o
- Page 316 and 317: Fig 3.5Brain lymphatic vessels.Give
- Page 318: ImmunityLymph nodes play an importa
- Page 321 and 322: Wound HealingAs with the blood vasc
- Page 323 and 324: Clinical ConsiderationFour continuo
- Page 325 and 326: Lymphatic InadequacyInadequacy in t
- Page 327 and 328: EdemaEdema - the medical term for s
- Page 329 and 330: Lymphatic treatment protocols will
- Page 331 and 332: CHAPTER 4NeurologyEach human nervou
- Page 333: NS StructureThe human NS comprises
- Page 337 and 338: Figure 4.1B Functional composition
- Page 339 and 340: Pathophysiological ConsiderationWhe
- Page 341 and 342: Figure 4.2Dorsal and ventral compon
- Page 344 and 345: Figure 4.3Neuron anatomy: most neur
- Page 346 and 347: Figure 4.4Classic axon to dendrite
- Page 349: Figure 4.6PNS efferent (motor) and
- Page 352 and 353: Clinical ConsiderationPSNS afferent
- Page 354 and 355: Clinical ConsiderationSNS activatio
- Page 357 and 358: Figure 4.8Anterior and posterior di
- Page 362 and 363: Pathophysiological ConsiderationA n
- Page 364 and 365: Clinical ConsiderationThere is an e
- Page 366 and 367: Clinical ConsiderationDiane Jacobs
- Page 368 and 369: Clinical ConsiderationIt appears th
- Page 370 and 371: Clinical ConsiderationAlthough musc
- Page 372 and 373: Clinical ConsiderationThe form of s
- Page 374 and 375: Example 2Ruffini stimulation result
- Page 376 and 377: Table 4.1Summary of receptor typolo
- Page 378 and 379: • Therapeutic outcome include enh
- Page 380 and 381: NS FunctionThe primary functions of
- Page 382 and 383: Clinical ConsiderationMechanorecept
- Page 384 and 385: Clinical ConsiderationIn addition t
- Page 386 and 387: Clinical ConsiderationManual techni
- Page 388 and 389: large enough, a voltage spike is pr
- Page 390 and 391: PathophysiologicalconsiderationUnde
- Page 392 and 393: Table 4.2Important pain terms. Vari
- Page 394 and 395: Clinical ConsiderationAccording to
- Page 396 and 397: disorders (diabetes mellitus), drug
- Page 398 and 399: forms of negative plasticity includ
- Page 400 and 401: Central and peripheral sensitizatio
- Page 402 and 403: Clinical ConsiderationFollowing per
- Page 404 and 405: ExampleHypersensitive nerves (assoc
- Page 406 and 407: Example 1Hypersensitized nerve fibe
- Page 408 and 409: Clinical ConsiderationIt is suggest
Figure 4.9
Neurofascial envelopes.